Skip to main content

Table 4 Cox regression model analyses of the gene expression levels in association with RFS of breast cancer patients

From: The prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer

 

RFS

Variable

HR

95% CI

P value

miR-10a > 0.53 V.S miR-10a0.53

2.31

1.00 ~ 5.32

0.0503

miR-10b > 0.67 V.S miR-10b0.67

3.96

1.21 ~ 12.98

0.0231

RUNX2 > 3.05 V.S RUNX23.05

3.02

1.50 ~ 6.07

0.0020

Number of overexpressing genes

   

0

1.00

  

1

2.80

0.30 ~ 25.77

0.3642

2

4.99

0.65 ~ 38.12

0.1212

3

12.37

1.62 ~ 94.55

0.0153

Additive model of gene overexpression

2.25

1.44 ~ 3.52

0.0004

  1. Adjusted for age.
  2. RFS: relapse-free survival, HR: Hazard ratio, CI: confidence interval, Gene overexpression: the expression level of an individual gene in tumor tissue normalized to adjacent non-tumor tissue from the same patient was categorized as “overexpression” by using the cutoff value determined from the ROC curve.
  3. Bold face: statistical significant (P value < 0.05).